With social media platforms, search algorithms and online research tools designed to let people upload, share, find and comment on information in real time, Sophie Fessl asks: why are we still reliant on a 350-year-old [more]
As ECCO’s new President-elect, Philip Poortmans is the first person to have a full democratic mandate from across all ECCO’s 24 member societies which, between them, represent the full range of healthcare professionals involved in [more]
For most of us, sooner or later, old age will bring frailty and chronic health conditions, making the task of living the life we wish progressively harder. We will want oncologists who know what different [more]
Delaying treatment for a curable prostate cancer is an increasingly popular option among men with low risk tumours. Simon Crompton looks at efforts to learn more about who benefits and how to avoid delaying too [more]
Prioritising collaboration over self-interest is the way to learn about who gets the best from which treatments in the complex world of advanced prostate cancer. Silke Gillessen talked to Simon Crompton about how she is [more]
The state of the art on the diagnosis and management of cancer of the pancreas and hepatobiliary system was the focus of the 3rd St Gallen Gastrointestinal Cancer Conference, held earlier this year under the [more]
An observational cohort study just published on the peer-reviewed journal Cancer concluded that the costs of breast cancer chemotherapy vary widely in the United States, even among treatment regimens with similar efficacy, and that patients [more]
The best chance of being cured of cancer is through surgery by expert surgeons with a deep knowledge of oncology. Why then are the public, patients and policy makers so focused on drugs, and does [more]
Looking for anticancer activity among off-patent drugs that are already approved to treat other conditions might seem a sensible way to speed up access to affordable new therapy options. Linda Geddes asks how such a [more]
Molecular imaging specialists are ready to break out of their research huddles and take their place at the heart of clinical decision making. But can they convince clinicians to welcome them in? Anna Wagstaff investigates. [more]
Eurocare, the landmark series of studies comparing survival of cancer patients among European countries, has been profoundly important in focusing attention on the quality of Europe’s cancer services over the past two decades. Now in [more]
Mr Lloyd is angry! His elderly mother is getting no treatment for her metastatic lung cancer, and he doesn’t want to hear what the doctors and nurses are saying… …A different approach by a new [more]
People with cancer need their care managed by a team of specialists who work together and learn and improve together. Simon Crompton reports on efforts to achieve such a collaborative approach in delivering prostate cancer [more]